Biotech
CAMBRIDGE, MA: Webcast Accessible via Sarepta Therapeutics Website ...
NEW YORK, NY: RDInvesting Provides Stocks Research on AVEO Pharmaceuticals and Aastrom Biosciences ...
NEW YORK, NY: RDInvesting Provides Stocks Research on Chelsea Therapeutics and Cyclacel Pharmaceuticals ...
MONTREAL, CANADA: MONTREAL, CANADA -- (Marketwire) -- 02/21/13 -- Paladin Labs Inc. (TSX: PLB), a leading Canadian specialty pharmaceutical company, will release its 2012 financial results on Thursday, February 28, 2 ...
EPALINGES, SWITZERLAND: - Vaccine-induced mucosal antibodies may contribute to reduce sexually transmitted HIV-1 - Immunogenicity of the HIV-1 vaccine confirmed both in serum and at the mucosal sites - Intramuscular and subs ...
EPALINGES, SWITZERLAND: - Vaccine-induced mucosal antibodies may contribute to reduce sexually transmitted HIV-1 - Immunogenicity of the HIV-1 vaccine confirmed both in serum and at the mucosal sites - Intramuscular and subs ...
MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwire) -- 02/20/13 -- Thallion Pharmaceuticals Inc. (TSX VENTURE: TLN) today announced its operational and financial results for the three-month and twelve-month periods en ...
SAN LEANDRO, CA: TriNet Companies Add New Jobs at Over 3x the Rate of the National Average; Tech Keeps Hiring, Biotech and Finance Slows ...
CAMBRIDGE, MA: CAMBRIDGE, MA -- (Marketwire) -- 02/20/13 -- Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a developer of innovative RNA-based therapeutics, will report fourth quarter and full-year 2012 financial resul ...
CHAPEL HILL, NC: CHAPEL HILL, NC -- (Marketwire) -- 02/20/13 -- (OTCQB: CWNM) is pleased to announce that patents for its have been approved and registered in Mexico.Mexico's pharmaceutical industry faces uniq ...
PARSIPPANY, NJ: Fourth Quarter Net Revenues Rise 20.6% to $159.5 Million; Full Year Net Revenues Rise 15.2% to $558.6 Million ...
MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwire) -- 02/20/13 -- Thallion Pharmaceuticals Inc. (TSX VENTURE: TLN) ("Thallion" or "Company") today announced that a Special Committee comprised of i ...
MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwire) -- 02/20/13 -- Thallion Pharmaceuticals Inc. (TSX VENTURE: TLN) ("Thallion") and LFB Biotechnologies ("LFB") today announced that they have reach ...
TORONTO, ONTARIO: Novel Combination of Neural Stem Cell Technology & Direct-to-Brain Administration of Therapeutics via an FDA-Cleared Neurocatheter ...
TORONTO, ONTARIO and MONTREAL, QUEBEC: TORONTO, ONTARIO and MONTREAL, QUEBEC -- (Marketwire) -- 02/20/13 -- In an effort to address ethical, legal and social issues (ELSI) as part of its activities to develop new regenerative medicine (RM ...
CARY, NC: CARY, NC -- (Marketwire) -- 02/20/13 -- Cornerstone Therapeutics Inc. (NASDAQ: CRTX) (the "Company") announced today that its Board of Directors has received a letter from Chiesi Farmaceuti ...
MISSION VIEJO, CA: MISSION VIEJO, CA -- (Marketwire) -- 02/19/13 -- (OTCQB: AOLS)(OTCQB: AOLS), a biotechnology company leveraging significant government funding to develop a platform of novel compounds to protect aga ...
MISSION VIEJO, CA: MISSION VIEJO, CA -- (Marketwire) -- 02/19/13 -- (OTCQB: AOLS), a biotechnology company leveraging significant government funding to develop a platform of novel compounds to protect against radiolog ...
TORONTO, ONTARIO: Novel Combination of Neural Stem Cell Technology & Direct-to-Brain Administration of Therapeutics via an FDA-Cleared Neurocatheter ...
